Fig. 1: Risk factors for infection in patients with MM receiving BsAbs.

BsAb bispecific antibody, CAR-T chimeric antigen receptor T-cell, CMV cytomegalovirus, HBV hepatitis B virus, IMiD immunomodulatory drug, MM multiple myeloma, PI proteasome inhibitors, PS propensity score, VZV varicella zoster virus.